The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Sniffing neuropeptides: a transnasal approach to the human brain
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Born et al. reported that, after giving 40IU (80µg) in man, CSF levels rose within 10min from ~5pg/ml to ~10pg/ml, increasing to ~20pg/ml at 60min (17).”
From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [17]
In the citing paper
“Born et al. achieved plasma concentrations of 20pg/ml after giving 40IU vasopressin (17).These are higher than Robertson et al. reported for any patient, including those with pathologically elevated vasopressin secretion; in man, maximal urine concentrating ability is achieved at a vasopressin concentration of ~5pg/ml (33).”
From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [17]
In the citing paper
“Estimating the CSF volume as 300ml, it seems that ~4.5ng of vasopressin reached the CSF: 0.005% of the given dose -assuming that the rise was due to administered peptide and not endogenous release triggered indirectly.”
From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [17]
In the citing paper
“neuropeptides have been shown to gain access to the brain following intranasal administration (Born et al., 2002;Chang et al., 2012).”
From Sex-specific effects of intranasal oxytocin on autonomic nervous system and emotional responses to couple conflict (2013) · cites this paper as Born et al., 2002
In the citing paper
“Using this delivery route, substantial amounts of insulin are delivered into the brain5”
From Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase (2023) · cites this paper as [5]
In the citing paper
“The intranasal dose administered in the present study has been associated with changes in central function in humans 58, and similar or smaller doses of oxytocin or vasopressin (24–48 IU for oxytocin; 40–80 IU for vasopressin) have been associated with elevations in peptide levels in the cerebrospinnal fluid in humans or macaques of no more than approximately 55 pg/ml in actual levels 70, 71, 72,”
From The Analgesic Effect of Oxytocin in Humans: A Double‐Blind, Placebo‐Controlled Cross‐Over Study Using Laser‐Evoked Potentials (2016) · cites this paper as [70]
In the citing paper
“Born and colleagues (5) showed that many neuropeptides crossed the blood-brain barrier when given intranasally.”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [5]
In the citing paper
“Since it was reported that the intranasal administration of neuropeptides increases their levels in cerebrospinal fluid (Born et al., 2002), there has been an upsurge of interest in experimental manipulations of central oxytocin in human populations (Bartz & Hollander, 2006; Campbell 2010; Heinrichs, von Dawans, & Domes, 2009).”
From Acute intranasal oxytocin improves positive self-perceptions of personality (2012) · cites this paper as Born et al., 2002
In the citing paper
“It is unlikely that the delay had any impact on the results, as previous research has shown that peptide concentrations in the cerebrospinal fluid remain relatively stable even 80 minutes after administration (Born et al., 2002).”
From Acute intranasal oxytocin improves positive self-perceptions of personality (2012) · cites this paper as Born et al., 2002
In the citing paper
“It is unlikely that the delay had any impact on the results, as previous research has shown that peptide concentrations in the cerebrospinal fluid remain relatively stable even 80 minutes after administration (Born et al., 2002).”
From Acute intranasal oxytocin improves positive self-perceptions of personality (2012) · cites this paper as Born et al., 2002
In the citing paper
“The discovery that intranasal administration of neuropeptides can reach the human central nervous system (17)”
From Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement (2012) · cites this paper as [17]
In the citing paper
“Intranasal administration of vasopressin (AVP) and of OXT have been reported, in rats and mice, to increase the intracerebral concentration of these peptides, not only in the cerebrospinal fluid but also in selected brain regions (Born et al, 2002;Neumann et al, 2013).”
From Chronic and acute intranasal oxytocin produce divergent social effects in mice (2014) · cites this paper as Born et al, 2002
In the citing paper
“The acute effects of intranasal oxytocin are reported to persist until 60–80 min post-administration.33, 34”
From Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial (2016) · cites this paper as [33]
In the citing paper
“It is estimated that only a small amount of intranasally administered oxytocin reaches the brain.33, 34, 46, 47”
From Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial (2016) · cites this paper as [33]
In the citing paper
“The direct manipulation of neuropeptidergic central nervous signaling pathways can be achieved via the intranasal administration of peptides, which is known to bypass the blood–brain barrier and result in significant cerebrospinal fluid elevations in substance levels within 40 min, without the need for systemic infusion (14,15).”
From Oxytocin Reduces Reward-Driven Food Intake in Humans (2013) · cites this paper as [14]
In the citing paper
“the exact transnasal-CNS route remains unknown, and the proportion of OXT that actually reaches the CNS is exceptionally small relative to the given dose (Born et al., 2002; Chang et al., 2012; Striepens et al., 2013; Dal Monte et al., 2014; Modi et al., 2014).”
From Marmosets treated with oxytocin are more socially attractive to their long-term mate (2015) · cites this paper as Born et al., 2002
In the citing paper
“These results suggest that intranasal administration rapidly upregulates OT levels in the brain and plasma during the timeframe of behavioral testing, and that OT clears the system several hours after testing.”
From Oxytocin facilitates fidelity in well-established marmoset pairs by reducing sociosexual behavior toward opposite-sex strangers (2014) · cites this paper as Born et al., 2002
In the citing paper
“Intranasally administered insulin is assumed to travel along olfactory and adjacent pathways and has been shown to rapidly accumulate in cerebrospinal fluid, indicating efficient transport to the brain.”
From Intranasal insulin (2021) · cites this paper as [35]
In the citing paper
“When acutely administered to humans at cumulative doses of up to 200 IU, IN insulin does not lead to large increases in systemic concentrations of the hormone 35 and appears to trigger side effects such as increases in cortisol and growth hormone only above this threshold.”
From Intranasal insulin (2021) · cites this paper as [35]
In the citing paper
“Experiments in healthy humans have shown that IN administered insulin bypasses the BBB and is detectable in CSF within 1 hour after administration.”
From Intranasal insulin (2021) · cites this paper as [35]
Citations
Cites
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Blood-brain barrier biology and methodology
Pardridge, W. M. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909021285 · Cited by 448
Quantitative analysis of the olfactory pathway for drug delivery to the brain
Thorne, R. G., Emory, C. R., Ala, T. A., & Frey, W. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00637-6 · Cited by 352
Cerebrospinal Fluid Insulin Levels Increase During Intravenous Insulin Infusions in Man*
Wallum, B. J., Taborsky, G. J., Porte, D., Figlewicz, D. P., Jacobson, L., Beard, J. C., Ward, W. K., & Dorsa, D. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-190 · Cited by 254
Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway
Chen, X., Fawcett, J. R., Rahman, Y., Ala, T. A., & Frey, W. H. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1102 · Cited by 247
Central nervous system effects of intranasally administered insulin during euglycemia in men.
Kern, W., Jan Born, A., Schreiber, H., & Fehm, H. (1999) · Diabetes · doi:10.2337/diabetes.48.3.557 · Cited by 192
Self-citationSchwartz, M. W., Bergman, R. N., Kahn, S. E., Taborsky, G. J., Fisher, L. D., Sipols, A. J., Woods, S. C., Steil, G. M., & Porte, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115431 · Cited by 183
Vasopressin and Memory Consolidation
de Wied, D., Greidanus, T. B. V. W., Bohus, B., Urban, I. J. A., & Gispen, W. H. (1976) · Progress in brain research · doi:10.1016/s0079-6123(08)60990-5 · Cited by 166
The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4–10Decreases Body Fat in Humans1
Fehm, H. L., Smolnik, R., Kern, W., McGregor, G. P., Bickel, U., & Jan Born, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7298 · Cited by 113
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Strand, F.L. Neuropeptides: Regulators of Physiological Process (MIT Press, Cambridge, 1999).
- Fehm, H.L., Smolnik, R., Kern, W. & Born, J. J. Clin. Endocrinol. Metab. 86, 1144–1148 (2001).
Cited by
Sorted by citations
Items 201–300 of 632
Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins
Nonaka, N., Farr, S. A., Kageyama, H., Shioda, S., & Banks, W. A. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132381 · Cited by 114
Heni, M., Wagner, R., Kullmann, S., Gancheva, S., Roden, M., Peter, A., Stefan, N., Preissl, H., Häring, H.-U., & Fritsche, A. (2017) · Diabetes · doi:10.2337/db16-1380 · Cited by 115
Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
Brown, A., Guess, N., Dornhorst, A., Taheri, S., & Frost, G. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13009 · Cited by 113
Oxytocin facilitates social approach behavior in women
Preckel, K., Scheele, D., Kendrick, K. M., Maier, W., & Hurlemann, R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00191 · Cited by 111
“Furthermore, Born et al. (2002) demonstrated that the intranasal administration of the related peptide arginine vasopressin (AVP) increases lumbar cerebrospinal fluid concentrations of AVP after 10 min, and that the AVP level peaks after 80 min.”
BackgroundCentral insulin modulates food valuation via mesolimbic pathways
Tiedemann, L. J., Schmid, S. M., Hettel, J., Giesen, K., Francke, P., Büchel, C., & Brassen, S. (2017) · Nature Communications · doi:10.1038/ncomms16052 · Cited by 113
Vasopressin, oxytocin, and social odor recognition
Wacker, D. W., & Ludwig, M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.08.014 · Cited by 112
Evolutionary origins of insulin resistance: a behavioral switch hypothesis
Watve, M. G., & Yajnik, C. S. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-61 · Cited by 114
Ditzen, B., Nater, U. M., Schaer, M., La Marca, R., Bodenmann, G., Ehlert, U., & Heinrichs, M. (2013) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nss083 · Cited by 112
“…and timing of the nasal spray administration were chosen based on published research on intranasal OT, behavior and emotions in humans (Meyer-Lindenberg et al., 2011) and on Born and colleagues’ results on cerebrospinal fluid levels after intranasal vasopressin administration (Born et al., 2002).”
BackgroundMethodInfluentialOxytocin in schizophrenia: a review of evidence for its therapeutic effects
MacDonald, K. S., & Feifel, D. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00634.x · Cited by 117
Strategies for Intranasal Delivery of Therapeutics for the Prevention and Treatment of NeuroAIDS
Hanson, L. R., & Frey, W. H. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9039-x · Cited by 111
Hallschmid, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12934 · Cited by 113
Nonsocial Functions of Hypothalamic Oxytocin
Yang, H.-P., Wang, L., Han, L., & Wang, S. C. (2013) · ISRN Neuroscience · doi:10.1155/2013/179272 · Cited by 116
Kullmann, S., Frank, S., Heni, M., Ketterer, C., Veit, R., Häring, H.-U., Fritsche, A., & Preissl, H. (2013) · Neuroendocrinology · doi:10.1159/000341406 · Cited by 110
Safety of intranasal human insulin: A review
Schmid, V., Kullmann, S., Gfrörer, W., Hund, V., Hallschmid, M., Lipp, H., Häring, H., Preissl, H., Fritsche, A., & Heni, M. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13279 · Cited by 110
Role of oxytocin signaling in the regulation of body weight
Blevins, J. E., & Ho, J. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9260-x · Cited by 108
Dash, S., Xiao, C., Morgantini, C., Koulajian, K., & Lewis, G. F. (2015) · Diabetes · doi:10.2337/db14-0685 · Cited by 108
Lochhead, J. J., & Davis, T. P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110598 · Cited by 111
Intranasal oxytocin, but not vasopressin, augments neural responses to toddlers in human fathers
Li, T., Chen, X., Mascaro, J., Haroon, E., & Rilling, J. K. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.01.006 · Cited by 105
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans
Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H., & Jacob, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.006 · Cited by 106
Oxytocin for the treatment of drug and alcohol use disorders
Lee, M. R., & Weerts, E. M. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000258 · Cited by 105
Social Decision-Making and the Brain: A Comparative Perspective
Tremblay, S., Sharika, K. M., & Platt, M. L. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.01.007 · Cited by 116
Rodriguez, M., Lapierre, J., Ojha, C. R., Kaushik, A. K., Batrakova, E. V., Kashanchi, F., Dever, S. M., Nair, M., & El‐Hage, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-01819-9 · Cited by 106
The blood-brain barrier and nasal drug delivery to the central nervous system
Miyake, M. M., & Bleier, B. S. (2015) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2015.29.4149 · Cited by 106
Oxytocin infusion increases charitable donations regardless of monetary resources
Barraza, J. A., McCullough, M. E., Ahmadi, S., & Zak, P. J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.04.008 · Cited by 106
Linnen, A.-M., Ellenbogen, M. A., Cardoso, C., & Joober, R. (2012) · Stress · doi:10.3109/10253890.2011.631154 · Cited by 104
A brief history of oxytocin and its role in modulating psychostimulant effects
Carson, D. S., Guastella, A. J., Taylor, E. R., & McGregor, I. S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112473788 · Cited by 105
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., Vaccarino, A., MacQueen, G., Lewis, G. F., & Kennedy, S. H. (2012) · Bipolar Disorders · doi:10.1111/bdi.12006 · Cited by 104
Microemulsion-Based Media in Nose-to-Brain Drug Delivery
Froelich, A., Osmałek, T. Z., Jadach, B., Puri, V., & Michniak‐Kohn, B. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020201 · Cited by 110
Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in women
Bethlehem, R. A. I., Lombardo, M. V., Lai, M.-C., Auyeung, B., Crockford, S. K., Deakin, J., Soubramanian, S., Sule, A., Kundu, P., Voon, V, et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.72 · Cited by 96
Early life stress modulates oxytocin effects on limbic system during acute psychosocial stress
Grimm, S., Pestke, K., Feeser, M., Aust, S., Weigand, A., Wang, J., Wingenfeld, K., Pruessner, J. C., Marca, R. L., Böker, H., et al. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsu020 · Cited by 106
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145565 · Cited by 102
Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders
Francis, S. M., Sagar, A., Levin-Decanini, T., Liu, W., Carter, C. S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.021 · Cited by 101
Behnia, B., Heinrichs, M., Bergmann, W., Jung, S., Germann, J., Schedlowski, M., Hartmann, U., & Kruger, T. H. C. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.01.009 · Cited by 103
Oxytocin for frontotemporal dementia
Finger, E. C., MacKinley, J. D., Blair, M., Oliver, L. D., Jesso, S., Tartaglia, M. C., BORRIE, M. J., Wells, J., Dziobek, I., Pasternak, S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001133 · Cited by 104
Intranasal insulin in Alzheimer's disease: Food for thought
Chapman, C. D., Schiöth, H. B., Grillo, C. A., & Benedict, C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.037 · Cited by 111
Intranasal oxytocin effects on social cognition: A critique
Evans, S. L., Dal Monte, O., Noble, P., & Averbeck, B. B. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.008 · Cited by 97
Acute intranasal oxytocin improves positive self-perceptions of personality
Cardoso, C., Ellenbogen, M. A., & Linnen, A.-M. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2527-6 · Cited by 98
CD38 and its role in oxytocin secretion and social behavior
Higashida, H., Yokoyama, S., Kikuchi, M., & Munesue, T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.011 · Cited by 98
Non-Invasive Strategies for Nose-to-Brain Drug Delivery.
Ja, T., Quispe, R. C., Khan, F. A., & Новак (2020) · PubMed · Cited by 114
Oxytocin decreases aversion to angry faces in an associative learning task
Evans, S., Shergill, S. S., & Averbeck, B. B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.110 · Cited by 97
Declerck, C. H., Boone, C., & Kiyonari, T. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst040 · Cited by 96
Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response
VIVIANI, D., & STOOP, R. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00418-4 · Cited by 96
Benedict, C., & Grillo, C. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00215 · Cited by 101
Slattery, D. A., & Neumann, I. D. (2010) · Pharmaceuticals · doi:10.3390/ph3030702 · Cited by 94
Schmidt, H., Kern, W., Giese, R. M., Hallschmid, M., & Enders, A. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062141 · Cited by 94
Self-citationXi, J., Yuan, J. E., Zhang, Y., et al. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1896-2 · Cited by 94
Hu, J., Qi, S., Becker, B., Luo, L., Gao, S., Gong, Q., Hurlemann, R., & Kendrick, K. M. (2015) · Human Brain Mapping · doi:10.1002/hbm.22760 · Cited by 98
Stern, S. A., Chen, D. Y., & Alberini, C. M. (2014) · Learning & Memory · doi:10.1101/lm.029348.112 · Cited by 89
Shpakov, A. O., Derkach, K. V., & Berstein, L. M. (2015) · Future Science OA · doi:10.4155/fso.15.23 · Cited by 93
Kellar, D., Lockhart, S. N., Aisen, P. S. S., Raman, R., Rissman, R. A., Brewer, J. B., & Craft, S. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.14 · Cited by 92
Exercise restores brain insulin sensitivity in sedentary adults who are overweight and obese
Kullmann, S., Goj, T., Veit, R., Fritsche, L., Wagner, L., Schneeweiß, P., Hoene, M., Hoffmann, C., Machann, J., Niess, A. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.161498 · Cited by 97
Kuypers, K. P. C., de la Torre, R., Farre, M., Yubero-Lahoz, S., Dziobek, I., Van den Bos, W., & Ramaekers, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100719 · Cited by 88
Bohringer, A., Schwabe, L., Richter, S., & Schachinger, H. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.002 · Cited by 89
Oxytocin, but not vasopressin, increases both parochial and universal altruism
Israel, S., Weisel, O., Ebstein, R. P., & Bornstein, G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.02.001 · Cited by 88
Maimaiti, S., Anderson, K. L., DeMoll, C., Brewer, L. D., Rauh, B. A., Gant, J. C., Blalock, E. M., Porter, N. M., & Thibault, O. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu314 · Cited by 86
Ayers, L. W., Missig, G., Schulkin, J. A., & Rosen, J. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.138 · Cited by 87
Adzovic, L., Lynn, A. E., D’Angelo, H. M., Crockett, A. M., Kaercher, R. M., Royer, S. E., Hopp, S. C., & Wenk, G. L. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0282-z · Cited by 88
Ionescu, I. A., Dine, J., Yen, Y.-C., Buell, D. R., Herrmann, L., Holsboer, F., Eder, M., Landgraf, R., & Schmidt, U. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.317 · Cited by 87
Oxytocin’s effect on resting-state functional connectivity varies by age and sex
Ebner, N. C., Chen, H., Porges, E., Lin, T., Fischer, H., Feifel, D., & Cohen, R. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.03.013 · Cited by 84
Prehn, K., Kazzer, P., Lischke, A., Heinrichs, M., Herpertz, S. C., & Domes, G. (2013) · Psychophysiology · doi:10.1111/psyp.12042 · Cited by 81
Oxytocin increases empathy to pain when adopting the other-but not the self-perspective
Abu-Akel, A., Palgi, S., Klein, E., Decety, J., & Shamay-Tsoory, S. (2015) · Social Neuroscience · doi:10.1080/17470919.2014.948637 · Cited by 83
Oxytocin enhances attention to the eye region in rhesus monkeys
Dal Monte, O., Noble, P. L., Costa, V. D., & Averbeck, B. B. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00041 · Cited by 80
Insulin Action in the Human Brain: Evidence from Neuroimaging Studies
Kullmann, S., Heni, M., Fritsche, A., & Preissl, H. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12254 · Cited by 83
Direct access of drugs to the human brain after intranasal drug administration?
Merkus, P., Guchelaar, H.-J., Bosch, D. A., & Merkus, F. W. H. M. (2003) · Neurology · doi:10.1212/01.wnl.0000067993.60735.77 · Cited by 81
Narcolepsy and the hypocretin system—where motion meets emotion
Siegel, J. M., & Boehmer, L. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0300 · Cited by 81
Effects of Intranasal Insulin on Hepatic Fat Accumulation and Energy Metabolism in Humans
Gancheva, S., Koliaki, C., Bierwagen, A., Nowotny, P., Heni, M., Fritsche, A., Häring, H.-U., Szendroedi, J., & Roden, M. (2015) · Diabetes · doi:10.2337/db14-0892 · Cited by 81
Neuroendocrine mechanisms of stress and social interaction: Implications for mental disorders
Heinrichs, M., & Gaab, J. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280146a13 · Cited by 79
A randomized dose-ranging study of neuropeptide Y in patients with posttraumatic stress disorder
Sayed, S., Van Dam, N. T., Horn, S. R., Kautz, M. M., Parides, M., Costi, S., Collins, K. A., Iacoviello, B., Iosifescu, D. V., Mathé, A. A., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx109 · Cited by 79
Attenuation of Kindled Seizures by Intranasal Delivery of Neuropeptide-Loaded Nanoparticles
Kubek, M. J., Domb, A. J., & Veronesi, M. C. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.02.001 · Cited by 79
Oxytocin and socioemotional aging: current knowledge and future trends
Ebner, N. C., Maura, G. M., MacDonald, K., Westberg, L., & Fischer, H. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00487 · Cited by 78
Hope, J. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/767482 · Cited by 84
Cerebral cortex: a target and source of insulin?
Csajbók, É., & Tamás, G. (2016) · Diabetologia · doi:10.1007/s00125-016-3996-2 · Cited by 85
Zwanenburg, R. J., Bocca, G., Ruiter, S., Dillingh, J. H., Flapper, B. C. T., van den Heuvel, E. R., & van Ravenswaaij‐Arts, C. M. A. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.109 · Cited by 81
Enhancing precision in human neuroscience
Nebe, S., Reutter, M., Baker, D. H., Bölte, J., Domes, G., Gamer, M., Gärtner, A., Gießing, C., Gurr, C., Hilger, K., et al. (2023) · eLife · doi:10.7554/elife.85980 · Cited by 81
Vasopressin increases human risky cooperative behavior
Brunnlieb, C., Nave, G., Camerer, C. F., Schosser, S., Vogt, B., Münte, T. F., & Heldmann, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518825113 · Cited by 78
Oxytocin, sexually dimorphic features of the social brain, and autism
Yamasue, H., Kuwabara, H., Kawakubo, Y., & Kasai, K. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01944.x · Cited by 78
Dose-Dependent Effects of Intranasal Insulin on Resting-State Brain Activity
Kullmann, S., Veit, R., Peter, A., Pohmann, R., Scheffler, K., Häring, H.-U., Fritsche, A., Preissl, H., & Heni, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01976 · Cited by 78
Recent advances in triacylglycerol mobilization by the gut
Xiao, C., Stahel, P., Carreiro, A. L., Buhman, K. K., & Lewis, G. F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.12.001 · Cited by 77
Oxytocin and the Pharmacological Dissection of Affiliation
Bartz, J. A. (2016) · Current Directions in Psychological Science · doi:10.1177/0963721415626678 · Cited by 77
Clark, I. A., Atwood, C., Bowen, R. L., Paz-Filho, G., & Vissel, B. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005850 · Cited by 76
Insulin resistance as the molecular link between diabetes and Alzheimer's disease
Abdalla, M. M. I. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1430 · Cited by 83
The other side of the coin: oxytocin decreases the adherence to fairness norms
Radke, S., & de Bruijn, E. R. A. (2012) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2012.00193 · Cited by 73
Role of Insulin in Neurotrauma and Neurodegeneration: A Review
Shaughness, M., Acs, D., Brabazon, F., Hockenbury, N., & Byrnes, K. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.547175 · Cited by 78
Oxytocin and vasopressin: Social neuropeptides with complex neuromodulatory functions
Benarroch, E. E. (2013) · Neurology · doi:10.1212/wnl.0b013e31828cfb15 · Cited by 74
Chang, S. W. C., & Platt, M. L. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.006 · Cited by 71
Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
Boyuklieva, R., & Pilicheva, B. (2022) · Biomedicines · doi:10.3390/biomedicines10071706 · Cited by 77
Oxytocin increases VTA activation to infant and sexual stimuli in nulliparous and postpartum women
Gregory, R., Cheng, H., Rupp, H. A., Sengelaub, D. R., & Heiman, J. R. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.12.009 · Cited by 72
Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects
Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72
Striepens, N., Matusch, A., Kendrick, K. M., Mihov, Y., Elmenhorst, D., Becker, B., Lang, M., Coenen, H. H., Maier, W., Hurlemann, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.026 · Cited by 71
Cavanaugh, J., Mustoe, A. C., Taylor, J. H., & French, J. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.020 · Cited by 72
Numan, M. (2020) · doi:10.1093/oso/9780190848675.001.0001 · Cited by 106
Jarcho, M. R., Mendoza, S. P., Mason, W. A., Yang, X., & Bales, K. L. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00677.x · Cited by 70
Bartz, J. A., Lydon, J. E., Kolevzon, A., Zaki, J., Hollander, E., Ludwig, N., & Bolger, N. (2015) · Psychological Science · doi:10.1177/0956797615580279 · Cited by 70
DeMayo, M. M., Song, Y. J. C., Hickie, I. B., & Guastella, A. J. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0248-y · Cited by 71
Tabak, B. A., Meyer, M. L., Castle, E., Dutcher, J. M., Irwin, M. R., Han, J. H., Lieberman, M. D., & Eisenberger, N. I. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.006 · Cited by 67
Peptide hormones regulating appetite—focus on neuroimaging studies in humans
Schloegl, H., Percik, R., Horstmann, A., Villringer, A., & Stumvoll, M. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1154 · Cited by 70
Central Insulin Administration Improves Odor-Cued Reactivation of Spatial Memory in Young Men
Brünner, Y. F., Kofoet, A., Benedict, C., & Freiherr, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3018 · Cited by 68
Oxytocin and vasopressin enhance responsiveness to infant stimuli in adult marmosets
Taylor, J. H., & French, J. A. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.10.002 · Cited by 68
Broadening the definition of brain insulin resistance in aging and Alzheimer's disease
Frazier, H. N., Ghoweri, A. O., Anderson, K. L., Lin, R., Porter, N. M., & Thibault, O. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.12.007 · Cited by 69
Oxytocin modulates fMRI responses to facial expression in macaques
Liu, N., Hadj-Bouziane, F., Jones, K. B., Turchi, J. N., Averbeck, B. B., & Ungerleider, L. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508097112 · Cited by 65
Metadata
- Authors
- Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L.
- Affiliations
- University of Lübeck (DE)
- Philipps University of Marburg (DE)
- Texas Tech University Health Sciences Center (US)
- Venue
- Nature Neuroscience
- Published
- 2002-05-06
- Volume
- 5
- Issue
- 6
- Pages
- 514-516
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2086190854
- Cited by
- 1,356
- References
- 14
- Citations by year
- 2026: 25 · 2025: 30 · 2024: 42 · 2023: 48 · 2022: 59 · 2021: 75 · 2020: 61 · 2019: 71 · 2018: 67 · 2017: 72 · 2016: 70 · 2015: 86 · 2014: 110 · 2013: 116 · 2012: 77
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- neuropeptides, intranasal drug delivery, blood-brain barrier bypass, cerebrospinal fluid, ACTH4-10, vasopressin, insulin
- MeSH terms
- Administration, Intranasal, Adrenocorticotropic Hormone, Adult, Brain, Female, Humans, Insulin, Male, Osmolar Concentration, Peptide Fragments, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
